Monitor the next 10-Q or 10-K for any unexpected adjustments or changes in accounting policies under PwC. The clean transition and Big 4-to-Big 4 switch suggest low risk, but the stock's historical poor performance on prior filings warrants caution.
CHRS drugs
CHRS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 16 $1.38entry
- T+1 · 5mo ago +0.72%α +1.97% · $1.39
- T+5 · 5mo ago +5.80%α +8.03% · $1.46
- T+20 · 4mo ago +5.07%α +4.87% · $1.45
- T+60 · 2mo ago −2.90%α −3.90% · $1.34
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Coherus Oncology dismissed Ernst & Young as its independent auditor and appointed PricewaterhouseCoopers, effective June 12, 2026. The filing states no disagreements with EY on accounting principles or audit scope, and a previously reported material weakness in internal controls over inventory reconciliations has been remediated. This is a routine auditor change between Big 4 firms with no adverse opinions or reportable events, carrying limited immediate stock impact.
Key Facts
- Ernst & Young (EY) was dismissed as independent auditor effective June 12, 2026.
- PricewaterhouseCoopers (PwC) was selected as the new independent auditor for fiscal year 2026, subject to standard client acceptance procedures.
- No disagreements (as defined in Item 304(a)(1)(iv)) occurred between Coherus and EY during fiscal years 2024, 2025, or the subsequent interim period.
- A material weakness in internal control over financial reporting related to inventory account reconciliations was reported in the 2024 10-K but was remediated as of the 2025 10-K.
- EY's letter to the SEC agrees with the statements in the 8-K's first four paragraphs.
Financial Impact
No direct financial impact; auditor change is administrative with no restatement or financial adjustments disclosed.
Risk Factors
- Potential undisclosed disagreements or control issues not captured in the filing.
- Market may interpret any auditor change negatively despite no adverse findings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-074090 |
| Document: chrs-20260612xex16d1.htm | 0001104659-26-074090 |
| Document: 0001104659-26-074090-index-headers.html | 0001104659-26-074090 |
| Document: 0001104659-26-074090-index.html | 0001104659-26-074090 |
| Document: 0001104659-26-074090.txt | 0001104659-26-074090 |
Track record
15 reports on CHRS
1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.97% at T+5 after the Feb 28, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Bearish 4/10 Entry $0.5250 Now $0.5060 +3.62% settles Feb 12
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $0.6409 Now $0.5060 −21.05% settles Feb 8
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $0.8984 Now $0.5060 −43.68% settles Jan 27
- Oct 14, 20264w ago Press Release Neutral 4/10 Entry $1.07 Now $0.5060 −52.71% settles Jan 12
- Aug 17, 202613w ago Press Release Neutral 4/10 Entry $1.34 to $0.6409 Now $0.5060 −62.24% ▼ −52.17% −50.13% vs SPY
- Jul 22, 202616w ago Press Release Neutral 1/10 Entry $1.43 to $1.07 Now $0.5060 −64.62% ▼ −25.17% −28.44% vs SPY
- Jun 15, 202622w ago 8-K Neutral 3/10 Viewing Entry $1.38 to $1.34 Now $0.5060 −63.33% ▼ −2.90% −3.90% vs SPY
- Jun 12, 202622w ago Institutional Cluster Bearish 4/10 Entry $1.40 to $1.37 Now $0.5060 +63.86% ▲ +2.14% +5.41% vs SPY
- May 28, 202624w ago DEFA14A Neutral 4/10 Entry $1.65 to $1.42 Now $0.5060 −69.33% ▼ −13.94% −15.67% vs SPY
- May 11, 202627w ago Press Release Mixed 6/10 Entry $1.71 to $1.27 Now $0.5060 −70.41% ▼ −26.02% −30.41% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers